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Abstract
We previously described the [3H]cGMP-binding characteristics of a CHAPS-solubilized protein that we proposed to be a
cGMP transporter. We now report the ATPase activity of the membrane-bound, solubilized and reconstituted form of a
cGMP transporter. The membrane-bound protein of unsealed ghosts had a linear ATPase activity over a 120 min incubation
period with optimal activity of about 400 pmol/mg/min. The apparent Km and Vmax for ATP were about 0.5 mM and
300 pmol/mg/min, respectively. When solubilized with CHAPS the specific activity of the protein was reduced to about
70 pmol/mg/min. Reconstitution of the CHAPS preparation into phospholipid bilayer using rapid detergent removal by
Extracti-gel0 column resulted in proteoliposomes which had ATPase activity similar to that found in the erythrocyte
membranes. The proteoliposomes displayed a linear ATP-dependent uptake of [3H]cGMP with an apparent Km value of
1.0 WM. This low Km-uptake of [3H]cGMP in proteoliposomes was not affected by 10 WM of AMP, cAMP and GMP, but
was completely abolished in the presence of the non-hydrolyzable ATP analogue, ATP-Q-S. Some ATPase activation was also
observed in the presence of 2 WM cAMP, but it is unclear whether this activity was coupled to the cGMP transporter. Our
results show that the membrane protein responsible for cGMP transport has an ATPase activity and transports the cyclic
nucleotide in the presence of ATP. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The existence of the intracellular signal molecule
guanosine 3P5P-cyclic monophosphate (cGMP) in
plasma and urine have been documented [1,2].
cGMP appears to be a biological marker since in-
creased extracellular levels of cGMP in patients
with heart failure [3^5] and with several types of
neoplastic diseases including cancer of the lung, co-
lon and breast [6] exist. Studies with di¡erent cell
types like endothelial and vascular smooth muscle
cells [7], hepatocytes [8,9] and human erythrocytes
[10,11] have shown that cGMP egression is an en-
ergy-requiring process. The e¥ux of cGMP may
serve not only the purpose of regulating the intra-
cellular levels of cGMP, but the released cyclic nu-
cleotide may also regulate the functions of other cells
like the inhibition of transepithelial sodium transport
in renal tubular cells [12]. Despite the signi¢cant role
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of adenosine 5P-triphosphate (ATP) in energizing
cGMP transport [10,11], the ATPase activity of the
transporter has yet not been characterized.
We previously demonstrated that the zwitterionic
detergent 3-[(3-cholamidopropyl) dimethylammonio]-
1-propanesulfate (CHAPS) is capable of solubilizing
and maintaining the cGMP-binding capacity of the
putative transporter [13]. In the present study, we
have made use of this information to isolate and
reconstitute the human erythrocyte cGMP transport-
er into lipid bilayer model membranes, and charac-
terize the cGMP-stimulated ATPase activities of the
protein and transport of cGMP.
2. Materials and methods
Ammonium molybdate, disodium-ATP, ATP-Q-S,
cGMP, GMP, cAMP, AMP, magnesium chloride,
sodium dodecyl sulfate (SDS), sodium metaarsenite
and L-K-phosphatidylcholine type II (from soybean)
were from Sigma Chemicals (St. Louis, MO, USA).
Extracti-Gel0 D was purchased from Pierce Chem-
ical Co. (Rockford, IL, USA). [3H]cGMP (speci¢c
activity 10 Ci/mmol) from Amersham International
(Amersham, Buckinghamshire, UK). All other chem-
icals were of analytical grade.
2.1. Preparation of erythrocyte ghosts
Blood from healthy human donors was sampled
into EDTA-vacutainer tubes and centrifuged at
600Ug for 15 min at 4‡C. After removing plasma
and bu¡y coat, the erythrocytes were resuspended
in the KR bicarbonate bu¡er (NaCl 121 mM, KCl
4.8 mM, KH2PO4 1.2 mM, NaHCO3 25.3 mM,
CaCl2 1.3 mM, with a pH of 8.0 at 20^22‡C) to
restore the original hematocrit. The cells were
washed and resuspended in the same bu¡er at 4‡C.
Unsealed membranes were prepared from washed
erythrocytes using the method of Dodge [14] with
slight modi¢cations. The packed erythrocytes were
lysed by resuspension in ice-cold deionized water
and centrifuged at 3U26 000Ug for 10 min. Mem-
branes (milky white) were resuspended in solubiliza-
tion bu¡er (10 mM Tris^HCl, 150 mM NaCl, pH 7.5
at 21‡C).
2.2. Membrane solubilization
Solubilization of membrane proteins by 0.5%
CHAPS (w/v) was performed using the method of
Doige [15] with slight modi¢cations. After shaking
the membrane-detergent suspension at 4‡C for
30 min, the mixture was centrifuged at 4‡C for 1 h
at 105 000Ug. The resulting supernatant (S1) was
removed and discarded. The pellet was resuspended
in the solubilization bu¡er to give a ¢nal protein
concentration of 0.4^0.5 mg/ml and 0.5% CHAPS
(w/v) was added. After 30 min incubation at 4‡C,
the sample was pelleted at 15 000Ug for 15 min at
4‡C. The resulting supernatant (S2) containing the
cGMP transport protein as well as other proteins
was removed carefully without pellet contamination,
reconstituted into liposomes and assayed for its ATP
hydrolytic and transport activities.
2.3. Proteoliposomes preparation
Proteoliposomes were prepared at 4‡C according
to the method of Horne [16] with certain modi¢ca-
tions. CHAPS (1% w/v)-solubilized soybean phos-
phatidylcholine (130 Wl of a 50 mg/ml solution) was
added to 400 Wl protein extract (S2). MgSO4 (54 Wl,
100 mM) was then added and the lipid^protein sus-
pension was shaken for 30 min. After incubation, the
mixture was applied to an Extracti-gel0 column
(1 ml) which has previously been treated with four
volumes of 10 mM Tris^HCl, 150 mM NaCl bu¡er
(pH 7.5) containing 2 mg/ml of bovine serum albu-
min and equilibrated with two volumes of 10 mM
Tris^HCl, 150 mM NaCl, 10 mM MgSO4 (pH 7.5).
Elution of proteoliposomes from the column was
done by using 1.5 ml of the equilibration bu¡er.
The proteoliposomes were sedimented in a microcen-
trifuge at 14 000Ug for 10 min at 4‡C and resus-
pended in 400 Wl of 10 mM Tris^HCl, 150 mM
NaCl bu¡er, pH 7.5. For a typical ATP hydrolysis
or [3H]cGMP uptake experiments, three of these re-
suspensions were employed.
2.4. Protein concentrations
Protein concentration was determined by a dye
binding assay [17] using reagents from Bio-Rad Lab-
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oratories (Richmond, CA, USA) and BSA from Sig-
ma Chemical (St. Louis, MO, USA) as standards.
2.5. ATPase activity assay
ATPase activity of the transporter in erythrocyte
ghosts, solubilized extract and its reconstituted form
was determined by measuring the release of inorganic
phosphate (Pi) from ATP, using the colorimetric
method of Chi¥et [18]. The experiment was per-
formed in duplicate and each reaction medium of
200 Wl contained 10 mM Tris^HCl, 150 mM NaCl
(pH 7.5), protein sample, 2 mM MgCl2 (if not oth-
erwise stated), 1 mM ATP (if not otherwise stated),
1 mM ouabain, and 2 mM EGTA with or without
2 WM cGMP. After incubation at 37‡C for up to
120 min, the reaction was stopped by the addition
of 200 Wl of 12% SDS. Ascorbic acid 6% (400 Wl) in
1 M HCl/1% ammonium molybdate was then added
for color development and the products stabilized
after 10 min by adding 600 Wl of 2% sodium cit-
rate/2% sodium metaarsenite/2% acetic acid. The ab-
sorbance of each sample at 850 nm was measured in
Pharmacia LKB-Ultrospec III (Pharmacia LKB Bio-
chrom Ltd, Cambridge CB4 4FJ, UK). The Pi re-
leased was calculated as the di¡erence between incu-
bations with and without cGMP.
2.6. [3H]cGMP uptake
The accumulation of cGMP into proteoliposomes
was assayed with the help of [3H]cGMP. The experi-
ment was performed in duplicate and each reaction
medium of 500 Wl contained 10 mM Tris^HCl, 150
mM NaCl (pH 7.5), proteoliposomes, 2 mM MgCl2
and 2 WM [3H]cGMP (if not otherwise stated) with
or without 1 mM ATP. After incubation at 37‡C for
up to 120 min, the reaction was stopped by adding
2 ml of ice-cold 10 mM Tris^HCl, 150 mM NaCl
(pH 7.5) and immediately ¢ltering through a Milli-
pore cellulose ¢lter type GS 0.22 which has previ-
ously been soaked in the same bu¡er. The ¢lters
were washed with 10 ml of 10 mM Tris^HCl,
150 mM NaCl (pH 7.5) and placed in scintillation
vials containing 0.5 ml of 1.0 M HCl and 9.5 ml of
scintillation liquid (Ultima Gold XR, Packard In-
strument B.V., The Netherlands). Radioactivity was
washed out of ¢lters by gentle shaking for 20 h, and
measured in a Packard Tri-Carb scintillation spec-
trometer, Model 1900TR (Packard, Meridian, MS,
USA). [3H]cGMP uptake was de¢ned as the di¡er-
ence between accumulations with and without ATP.
2.7. Thin layer chromatography
The purity of the radiolabelled cGMP was exam-
ined with thin layer chromatography in three di¡er-
ent systems: 0.3 M LiCl/PEI cellulose, 1.0 M
KH2PO4, pH 3.4/PEI cellulose and ethanol:1.0 M
ammonium acetate (50:20)/Silica gel 60. In each sys-
tem the radioactivity associated with the proteolipo-
somes was found in a single peak with the same Rf
value as the native substance.
2.8. Statistics
The results are presented as mean value þ S.D.
3. Results
3.1. cGMP stimulation of ATPase activity in unsealed
ghosts
The transport system for cGMP has been demon-
strated to be coupled to an ATPase since ATP, but
not the non-hydrolyzable ATP analogues AMP^PNP
and ATP-Q-S, supports cGMP transport [11]. In Fig.
1 (upper panel) we show that human erythrocyte
membranes do possess intrinsic cGMP-stimulated
ATPase activity. The production of free Pi from
ATP was determined as the di¡erence between incu-
bations with and without cGMP. The rate of free Pi
released was linear over a 120 min period and was
found to be reproducible. The mean stimulated ATP-
ase activity of three separate erythrocyte membrane
preparations was 383 þ 27 pmol/mg/min. In spite of
the fact that incubations contained Ca2 and Na,
K-ATPase inhibitors, EGTA and ouabain, respec-
tively, an appreciably high level of basal ATPase
activity was observed (278 þ 90 pmol/mg/min) in the
absence of cGMP. Based on the data presented in
Fig. 1 (middle panel), kinetic constants for the ATP
hydrolysis in erythrocyte membranes from three sep-
arate experiments yielded an apparent Km value for
ATP of 0.48 þ 0.26 mM and a Vmax value of 280 þ 70
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pmol/mg protein/min. The divalent cation, Mg2, is a
well-known activator of various ATPases [19] and
has recently been reported to activate cGMP uptake
into inside-out vesicles from human erythrocytes
[20,21]. In the present study Mg2 caused a concen-
tration-dependent activation of the cGMP-stimulated
ATPase activity (Fig. 1, lower panel). Under the
present experimental conditions, the apparent Km
and Vmax values for Mg2 were 3.05 þ 0.9 mM and
520 þ 210 pmol/mg protein/min, respectively.
3.2. ATPase activity in solubilized extract
Solubilization of the erythrocyte membranes by
0.5% CHAPS (w/v) resulted in an extract with ATP-
ase activity. The di¡erence in Pi released between
incubations with and without (2 WM) cGMP is de-
¢ned as cGMP-speci¢c activity and showed linearity
(y = 0.29122+0.062875x, r = 0.99). However, the rate
of free Pi produced by the extract was about ¢ve
times less than observed in the ghosts. The basal
and stimulated ATPase activity of four distinct ex-
tracts were 21 þ 3 pmol/mg/min and 66 þ 16 pmol/
mg/min (mean þ S.D.), respectively.
3.3. ATPase activity and [3H]cGMP uptake in
proteoliposomes
When detergent was removed and proteins recon-
stituted into liposomes, ATPase activity was raised to
a level similar to that found in the unsealed ghosts.
The background and stimulated ATPase activity of
three separate proteoliposomes preparations were
257 þ 66 pmol/mg/min and 304 þ 35 pmol/mg/min, re-
spectively. Fig. 2 (upper panel) shows a linear
cGMP-speci¢c ATPase activity up to 120 min at
37‡C. [3H]cGMP accumulated in proteoliposomes
Fig. 1. cGMP-stimulated ATPase activity in unsealed erythro-
cyte ghosts. Human erythrocyte membranes (40^60 Wg) were in-
cubated with and without 2 WM cGMP in 200 Wl incubation
bu¡er. After incubation at 37‡C for up to 120 min, the ATPase
activity was measured colorimetrically by following the produc-
tion of Pi. Pi released is given as the di¡erence between incuba-
tions with and without cGMP. Upper panel : Time course of
cGMP-stimulated ATPase activity in unsealed erythrocyte
ghosts. Pi released can be described by the linear correlation
y = 3.6+0.3x (r = 0.98). Results are presented as mean þ S.D.
(n = 3). Middle panel : ATP dependency of cGMP-stimulated
ATPase activity in erythrocyte unsealed ghosts. Membranes
were incubated with various concentrations of ATP (0.4^2 mM).
After incubation for 120 min, the Pi released was measured and
can be described by the linear correlation y = 3.3889+1.8361x
(r = 0.98). Results are presented in Lineweaver^Burk plot, mean
value þ S.D. (n = 3). Lower panel: Mg2-dependency of cGMP-
stimulated ATPase activity. Membranes were incubated with
various concentrations of MgCl2 (1^5 mM). After incubation
for 120 min, the Pi released was measured and can be described
by the linear correlation y = 2.2686+6.2878x (r = 0.99). Results
are presented in a Lineweaver^Burk plot, mean value þ S.D.
(n = 3).
6
BBAMEM 77992 6-12-00
E. Boadu, G. Sager / Biochimica et Biophysica Acta 1509 (2000) 467^474470
up to 90 min with and without ATP (Fig. 2, middle
panel). The ATP-dependent uptake of cGMP (i.e.
active transport of cGMP) in proteoliposomes, de-
¢ned as the di¡erence in accumulated [3H]cGMP in
presence and absence of ATP, was linear (Fig. 2,
lower panel). The mean uptake in three distinct pro-
teoliposomes preparations was 214 þ 82 fmol/mg/
min.
Fig. 2. Re-established cGMP-stimulated ATPase activity and
[3H]cGMP uptake in reconstituted erythrocyte membrane pro-
teins (15 Wg protein). Proteoliposomes were obtained as de-
scribed in Section 2. Upper panel : Time course of ATPase ac-
tivity in proteoliposomes incubated at 37‡C for up to 120 min
with and without 2 WM cGMP in the incubation medium de-
scribed in Section 2. Pi released is given as the di¡erence be-
tween incubations with and without cGMP. Results are pre-
sented as mean þ S.D. ( = 3). Middle panel: Time course of
[3H]cGMP uptake in proteoliposomes at 37‡C. Proteoliposomes
were exposed to 2 WM [3H]cGMP in the presence or absence of
1 mM ATP in the incubation medium described in Section 2.
Separation of proteoliposomes from medium was accomplished
by dilution and ¢ltration. [3H]cGMP uptake with (a-a) and
without (b-b) ATP. Results are presented as mean þ S.D.
(n = 3). Lower panel : Active [3H]-cGMP uptake is given as the
di¡erence between incubations with and without ATP (a-a)
and can be described by the linear correlation
y = 2.1807+0.19245x (r = 0.98). Results are presented as
mean þ S.D. (n = 3).
6
Fig. 3. The e¡ect of ATP-Q-S on [3H]cGMP uptake in reconsti-
tuted erythrocyte membrane proteins (15 Wg protein). Proteoli-
posomes were exposed to 0.2^4 WM [3H]cGMP in the presence
and absence of 1 mM ATP or 1 mM ATP-Q-S. Separation of
proteoliposomes from medium was accomplished by dilution
and ¢ltration. Results are presented as [3H]cGMP uptake with
(a-a) and without (8-8) ATP and with (b-b) ATP-Q-S
(mean þ S.D., n = 3).
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We have previously shown that ATP, but not the
non-hydrolyzable ATP analogue adenosine 5P-O-(3-
thiotriphosphate) (ATP-Q-S), supports cGMP trans-
port into inside-out vesicles from human erythrocytes
[11]. Fig. 3 shows that [3H]cGMP accumulated in
proteoliposomes with ATP, ATP-Q-S, and also with-
out ATP. The ATP-dependent uptake of cGMP was
de¢ned as the di¡erence in accumulated [3H]cGMP
in presence and absence of ATP and it showed a
concentration-dependent increase, whereas virtually
no di¡erence existed between [3H]cGMP accumula-
tion in the presence of ATP-Q-S and in absence of
ATP. Scatchard analysis [22] of the data obtained
from experiments with and without ATP (Fig. 3)
gave an apparent Km value of 1.05 þ 0.4 WM.
3.4. E¡ects of nucleotides on ATP hydrolysis and
[3H]cGMP uptake in proteoliposomes
Stimulation of ATP hydrolysis in proteoliposomes
by some nucleotides is presented in Table 1. cGMP-
stimulated ATP hydrolysis was about ¢vefold that of
cAMP whereas the non-cyclic nucleotides (AMP and
GMP), had no stimulatory e¡ect. The inhibition of
[3H]cGMP accumulation in proteoliposomes by these
nucleotides is presented in Table 2. Among the nu-
cleotides tested (AMP, cAMP, GMP, cGMP), only
cGMP e¡ectively inhibited the uptake of the radio-
ligand by proteoliposomes. The other nucleotides
did not show any inhibitory e¡ect on [3H]cGMP up-
take.
4. Discussion
Direct biochemical evidence to demonstrate that
cGMP transporter functions as an ATPase will be
an invaluable support to the concept that the mem-
brane protein utilizes ATP in energizing cGMP ef-
£ux. In this study we have shown the ATPase activ-
ity of a cGMP transporter in unsealed human
erythrocyte membranes and made an initial charac-
terization of the catalysis. Based on the evidence that
ATPase activities of several transporter ATPases are
directly regulated by the transported substrate, e.g.,
the Ca2- and Na/K-ATPases [23], Cl3- ATPase
[24], the arsenite/antimonite ATPase [25], and the
several organic molecule ATP-dependent transport-
ers like the bacterial histidine and maltose permeases
[26,27], the erythrocyte glutathione disul¢de trans-
porter [28] and P-glycoprotein (P-gp) [29], cGMP
was used in stimulating the ATPase activity of the
cGMP transporter.
Unsealed erythrocyte membrane exhibits cGMP-
stimulated ATPase activity with a Km value for
ATP being comparable to that of other transporter
ATPases, e.g., ArsA protein [25], CFTR [30], P-gp
[15,29,31^33] and identical to the value obtained in
cGMP transport studies [20]. The a⁄nity of the
transporter for the divalent cation, Mg2, is in the
range reported for P-gp (2^10 mM) [31] and virtually
similar to the Km value observed for the activation of
cGMP uptake into inside-out vesicles from human
erythrocytes in a recent report [21]. CHAPS, unlike
Table 2
Inhibition of [3H]cGMP uptake in proteoliposomes by nucleo-
tides
Nucleotide Percent of control
AMP 115
cAMP 129
GMP 94
cGMP 0
Proteoliposomes were exposed to 2 WM [3H]cGMP, 2 mM
MgCl2 with and without 1 mM ATP in the presence or absence
of 10 WM nucleotide (AMP, cAMP, GMP or cGMP) at 37‡C
for 90 min. Separation of proteoliposomes from medium was
accomplished by dilution and ¢ltration. [3H]cGMP uptake is
de¢ned as the di¡erence in incubations with and without ATP.
The results are presented as mean value of triplicate experi-
ments.
Table 1
E¡ects of nucleotides on ATP hydrolysis by cGMP transporter
Nucleotide Free Pi released (nmol/mg)
AMP 0
cAMP 4.4 þ 0.7
GMP 0
cGMP 23 þ 5
Proteoliposomes were incubated with and without 2 WM of nu-
cleotide (AMP, cAMP, GMP, or cGMP) in 200 Wl incubation
bu¡er. After incubation at 37‡C for 120 min, ATP hydrolysis
was measured colorimetrically by assaying the production of Pi.
Pi released is given as the di¡erence between incubations with
and without nucleotide. Results are presented as mean þ S.D.
(n = 3).
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other detergents, is known to preserve ATPase activ-
ity in proteins, e.g., P-gp [34] but reduces the activity
by 50% or abolishes it completely when assayed in
the presence of 1.6^9 mM of the detergent
[29,31,32,34]. The low ATPase activity observed in
the CHAPS-solubilized extract may be due to the
e¡ects of the detergent. Thus, the CHAPS might
have caused delipidation and/or unfolding of the
protein resulting in the disruption of the interaction
between the substrate-binding site(s) and ATPase do-
main. The cGMP transporter, like other membrane-
bound protein ATPases (e.g., Ca2- and Na/K-
ATPases, and P-gp), appears therefore to require a
lipid environment for ATPase activity. Reconstitu-
tion of the transporter into liposomes made up of
phosphatidylcholine, a phospholipid suitable for re-
constitution and transport studies of erythrocyte
membrane proteins [35^37], increased the ATPase
activity to the level observed in membranes. This
supports the concept mentioned above that the ATP-
ase domain of the transporter requires stabilization
of the transmembrane domain in a hydrophobic en-
vironment for its optimal activity.
We have successfully used reconstituted erythro-
cyte membrane extract to demonstrate cGMP uptake
by a transport protein. The proteoliposome behaves
qualitatively like cGMP transporter with respect to
the use of ATP in translocating cGMP. Despite the
fact that active cGMP uptake was linear (Fig. 2,
lower panel), we could not estimate the stoichiometry
of cGMP transported because this requires reconsti-
tution of pure protein. In contrast to the observa-
tions for inside-out vesicles [10], the amount of
[3H]cGMP associated with the proteoliposomes in
absence of ATP increased linearly (Fig. 2, middle
panel). The fact that the apparent uptake of cGMP
was identical in incubations with ATP-Q-S and with-
out ATP (Fig. 3) demonstrates an ATP-independent
process. This observation shows that the proteolipo-
some ‘membrane’ di¡ers markedly from the cell
membrane which is virtually impermeable to cGMP
since concentration-gradients of 200 or more, is
needed to load intact cells [38]. The proteoliposomes
may have pores that allow di¡usion into the vesicles
or non-saturable binding (partition) to the arti¢cial
membrane.
The low Km (1.0 WM) for [3H]cGMP uptake is in
agreement with our previous observations on active
cGMP transport across the human erythrocyte mem-
brane [10,11,38]. If this active transport system obeys
Michaelis^Menten kinetics, then saturation occurs at
concentrations below 10 WM. In agreement, this con-
centration of unlabelled cGMP abolished the uptake
of the tracer. On the other hand, identical concen-
trations of cAMP, AMP, and GMP did not hinder
the uptake of [3H]cGMP. This suggests a consider-
able degree of speci¢city in ranges of physiological
concentrations. However, cAMP caused some ATP-
ase activation and may re£ect a loss of transport
speci¢city at high cAMP concentration. In accor-
dance, cAMP inhibited cGMP transport [11] with
an estimated Ki of 0.8^3 mM. Another possibility
is that the cAMP-induced ATPase activity is linked
to a speci¢c cAMP pump. Di¡erent pro¢les for the
extrusion are observed for cGMP and cAMP [7,39]
with cGMP showing a prolonged time of egress after
the stimulation compared to an immediate rise and
fall for cAMP. Furthermore, vinblastine, which is
shown to reduce the export of cAMP [40] had no
e¡ect on the cGMP export [8]. However, cAMP
transport shares at least some characteristics of
cGMP transport, like the fact that the extrusion pro-
cess is inhibited by probenecid [7,41,42]. Further
studies are needed to clarify whether cAMP and
cGMP share a common transporter.
The data of the present study strongly show that
human erythrocyte membrane possesses an intrinsic
cGMP transport system that utilizes ATP for its ac-
tivity since no di¡erence was evident in apparent
[3H]cGMP uptake without ATP and with the non-
hydrolyzable ATP-analogue, ATP-Q-S. The need of
ATP makes the cGMP transporter a potential mem-
ber of the superfamily of ATP-binding cassette
(ABC) transporters [43]. In agreement with this
idea, MRP5 has recently been shown to transport
cGMP and other nucleotides [44,45]. Most of the
data we have accumulated on active cGMP transport
[10,11,20,21,38] are consistent with MRP5 being the
transport protein and include the cGMP pump in the
family of ABC-transporters.
Acknowledgements
This work was supported by The Norwegian Can-
cer Society.
BBAMEM 77992 6-12-00
E. Boadu, G. Sager / Biochimica et Biophysica Acta 1509 (2000) 467^474 473
References
[1] A.E. Broadus, J.G. Hardman, N.I. Kaminsky, J.H. Ball,
E.W. Sutherland, G.W. Liddle, Ann. N. Y. Acad. Sci. 185
(1971) 50^66.
[2] F. Murad, C.Y. Pak, N. Engl. J. Med. 286 (1972) 1382^1387.
[3] K.P. Vorderwinkler, E. Artner-Dworzak, G. Jakob, J. Mair,
F. Diensti, M. Pichler, B. Puschendorf, Clin. Chem. 37
(1991) 186^190.
[4] W.T. Abraham, J. Hensen, J.K. Kim, J. Durr, E.J. Lesnef-
sky, B.M. Groves, R.W. Schrier, J. Am. Soc. Nephrol. 2
(1992) 1697^1703.
[5] G. Jakob, J. Mair, K.P. Vorderwinkler, G. Judmaier, P.
Konig, H. Zwierzina, M. Pichler, B. Puschendorf, Clin.
Chem. 40 (1994) 96^100.
[6] R.K. Chawla, S.M. Shlaer, D.H. Lawson, T.G. Murray, F.
Schmidt, M. Shoji, D.W. Nixon, A. Richmond, D. Rudman,
Cancer Res. 40 (1980) 3915^3920.
[7] P. Hamet, S.C. Pang, J. Tremblay, J. Biol. Chem. 264 (1989)
12364^12369.
[8] M.L. Tjornhammar, G. Lazaridis, T. Bartfai, J. Biol. Chem.
258 (1983) 6882^6886.
[9] T.R. Billiar, R.D. Curran, B.G. Harbrecht, J. Stadler, D.L.
Williams, J.B. Ochoa, M. DiSilvio, R.L. Simmons, S.A.
Murray, Am. J. Physiol. 262 (1992) C1077^1082.
[10] G. Sager, A. Orbo, R.H. Pettersen, K.E. Kjorstad, Scand.
J. Clin. Lab. Invest. 56 (1996) 289^293.
[11] C. Schultz, S. Vaskinn, H. Kildalsen, G. Sager, Biochemistry
37 (1998) 1161^1166.
[12] R.L. Chevalier, G.D. Fang, M. Garmey, Am. J. Physiol. 270
(1996) F283^288.
[13] E. Boadu, G. Sager, Biochemistry 36 (1997) 10954^10958.
[14] J.T. Dodge, C. Mitchell, D.J. Hanahan, Arch. Biochem. Bio-
phys. 100 (1963) 119^130.
[15] C.A. Doige, X. Yu, F.J. Sharom, Biochim. Biophys. Acta
1109 (1992) 149^160.
[16] W.A. Horne, G.A. Weiland, R.E. Oswald, R.A. Cerione,
Biochim. Biophys. Acta. 863 (1986) 205^212.
[17] M.M. Bradford, Anal. Biochem. 72 (1976) 248^254.
[18] S. Chi¥et, A. Torriglia, R. Chiesa, S. Tolosa, Anal. Bio-
chem. 168 (1988) 1^4.
[19] K. Sigler, Folia Microbiol. 27 (1982) 195^210.
[20] S. Vaskinn, E. Sundkvist, R. Jaeger, G. Sager, Mol. Membr.
Biol. 16 (1999) 181^188.
[21] E. Sundkvist, R. Jaeger, G. Sager, Biochim. Biophys. Acta
1463 (2000) 121^130.
[22] G. Scatchard, Ann. N. Y. Acad. Sci. 51 (1949) 660^672.
[23] E. Racker, in: Reconstitutions of Transporters, Receptors,
and Pathological States, Academic Press, Orlando, FL, 1985,
pp. 87^103.
[24] G.A. Gerencser, S.H. Lee, Am. J. Physiol. 248 (1985) R241^
248.
[25] C.M. Hsu, B.P. Rosen, J. Biol. Chem. 264 (1989) 17349^
17354.
[26] L. Bishop, R. Agbayani Jr., S.V. Ambudkar, P.C. Maloney,
G.F. Ames, Proc. Natl. Acad. Sci. USA 86 (1989) 6953^
6957.
[27] D.A. Dean, A.L. Davidson, H. Nikaido, Proc. Natl. Acad.
Sci. USA 86 (1989) 9134^9138.
[28] T. Kondo, Y. Kawakami, N. Taniguchi, E. Beutler, Proc.
Natl. Acad. Sci. USA 84 (1987) 7373^7377.
[29] A.B. Shapiro, V. Ling, J. Biol. Chem. 269 (1994) 3745^3754.
[30] C.H. Li, M. Ramjeesingh, W. Wang, E. Garami, M. He-
wryk, D. Lee, J.M. Rommens, K. Galley, C.E. Bear,
J. Biol. Chem. 271 (1996) 28463^28468.
[31] H. Hamada, T. Tsuruo, Cancer Res. 48 (1988) 4926^4932.
[32] B. Sarkadi, E.M. Price, R.C. Boucher, U.A. Germann, G.A.
Scarborough, J. Biol. Chem. 267 (1992) 4854^4858.
[33] M.K. alShawi, A.E. Senior, J. Biol. Chem. 268 (1993) 4197^
4206.
[34] C.A. Doige, X. Yu, F.J. Sharom, Biochim. Biophys. Acta
1146 (1993) 65^72.
[35] U. Scheuring, K. Kollewe, W. Haase, D. Schubert,
J. Membr. Biol. 90 (1986) 123^135.
[36] M.E. Auland, B.D. Roufogalis, P.F. Devaux, A. Zachowski,
Proc. Natl. Acad. Sci. USA 91 (1994) 10938^10942.
[37] J.M. Boulter, A.M. Taylor, A. Watts, Biochim. Biophys.
Acta 1280 (1996) 265^271.
[38] K. Flo, M. Hansen, A. Orbo, K.E. Kjorstad, J.M. Maltau,
G. Sager, Scand. J. Clin. Lab. Invest. 55 (1995) 715^721.
[39] R.F. O’Dea, C. Gagnon, M. Zatz, J. Neurochem. 31 (1978)
733^738.
[40] C.D. King, S.E. Mayer, Mol. Pharmacol. 10 (1974) 941^953.
[41] M.L. Tjornhammar, G. Lazaridis, T. Bartfai, Neurosci. Lett.
68 (1986) 95^99.
[42] G.B. Henderson, B.P. Strauss, J. Biol. Chem. 266 (1991)
1641^1645.
[43] C.F. Higgins, Annu. Rev. Cell Biol. 8 (1992) 67^113.
[44] G. Jedlitschky, B. Burchell and D. Keppler, J. Biol. Chem.
(2000) in press.
[45] J. Wijnholds, C.A. Mol, L. van Deemter, M. de Haas, G.L.
Sche¡er, F. Baas, J.H. Beijnen, R.J. Scheper, S. Hatse, E. De
Clercq, J. Balzarini, P. Borst, Proc. Natl. Acad. Sci. USA 97
(2000) 7476^7481.
BBAMEM 77992 6-12-00
E. Boadu, G. Sager / Biochimica et Biophysica Acta 1509 (2000) 467^474474
